UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Plasmonically Enhanced Upconversion Luminescence via Holographically Formed Silver Nanogratings Journal article
ACS Applied Materials and Interfaces, 2020,Volume: 12,Issue: 1,Page: 1292-1298
Authors:  Chu,Anshi;  He,Huilin;  Yin,Zhen;  Peng,Ruiheng;  Yang,Hongcheng;  Gao,Xian;  Luo,Dan;  Chen,Rui;  Xing,Guichuan;  Liu,Yan Jun
Favorite |  | TC[WOS]:3 TC[Scopus]:3 | Submit date:2021/03/11
core-shell nanorod  holographical synthesis  nanograting  plasmonic enhancement  upconversion  
Botanical drug puerarin promotes neuronal survival and neurite outgrowth against mptp/mpp+-induced toxicity via progesterone receptor signaling Journal article
Oxidative Medicine and Cellular Longevity, 2020,Volume: 2020
Authors:  Zhao,Yingke;  Zhao,Jia;  Zhang,Xiuying;  Cheng,Yuanyuan;  Luo,Dan;  Lee,Simon Ming Yuen;  Lao,Lixing;  Rong,Jianhui
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2021/03/01
N-Propargyl Caffeamide (PACA) Ameliorates Dopaminergic Neuronal Loss and Motor Dysfunctions in MPTP Mouse Model of Parkinson's Disease and in MPP+-Induced Neurons via Promoting the Conversion of proNGF to NGF Journal article
MOLECULAR NEUROBIOLOGY, 2018,Volume: 55,Issue: 3,Page: 2258-2267
Authors:  Luo, Dan;  Zhao, Jia;  Cheng, Yuanyuan;  Lee, Simon Ming-Yuen;  Rong, Jianhui
Favorite |  | TC[WOS]:14 TC[Scopus]:15 | Submit date:2018/10/31
Parkinson's disease  Neuroprotection  N-propargyl caffeamide (PACA)  NGF/TrkApathway  PI3K/Akt  ERK1/2  
N-Propargyl Caffeamide (PACA) Ameliorates Dopaminergic Neuronal Loss and Motor Dysfunctions in MPTP Mouse Model of Parkinson's Disease and in MPP+-Induced Neurons via Promoting the Conversion of proNGF to NGF Journal article
MOLECULAR NEUROBIOLOGY, 2018,Volume: 55,Issue: 3,Page: 2258-2267
Authors:  Luo, Dan;  Zhao, Jia;  Cheng, Yuanyuan;  Lee, Simon Ming-Yuen;  Rong, Jianhui
Favorite |  | TC[WOS]:14 TC[Scopus]:15 | Submit date:2018/10/30
Parkinson's disease  Neuroprotection  N-propargyl caffeamide (PACA)  NGF/TrkApathway  PI3K/Akt  ERK1/2  
N-Propargyl Caffeamide (PACA) Ameliorates Dopaminergic Neuronal Loss and Motor Dysfunctions in MPTP Mouse Model of Parkinson's Disease and in MPP+-Induced Neurons via Promoting the Conversion of proNGF to NGF Journal article
MOLECULAR NEUROBIOLOGY, 2018,Volume: 55,Issue: 3,Page: 2258-2267
Authors:  Luo, Dan;  Zhao, Jia;  Cheng, Yuanyuan;  Lee, Simon Ming-Yuen;  Rong, Jianhui
Favorite |  | TC[WOS]:14 TC[Scopus]:15 | Submit date:2018/10/31
Parkinson's disease  Neuroprotection  N-propargyl caffeamide (PACA)  NGF/TrkApathway  PI3K/Akt  ERK1/2  
N-Propargyl Caffeamide (PACA) Ameliorates Dopaminergic Neuronal Loss and Motor Dysfunctions in MPTP Mouse Model of Parkinson's Disease and in MPP+-Induced Neurons via Promoting the Conversion of proNGF to NGF Journal article
MOLECULAR NEUROBIOLOGY, 2018,Volume: 55,Issue: 3,Page: 2258-2267
Authors:  Luo, Dan;  Zhao, Jia;  Cheng, Yuanyuan;  Lee, Simon Ming-Yuen;  Rong, Jianhui
Favorite |  | TC[WOS]:14 TC[Scopus]:15 | Submit date:2018/10/30
Parkinson's disease  Neuroprotection  N-propargyl caffeamide (PACA)  NGF/TrkApathway  PI3K/Akt  ERK1/2